Patent: RE37343
✉ Email this page to a colleague
Summary for Patent: RE37343
Title: | Expression and secretion of heterologous proteins in yeast employing truncated alpha-factor leader sequences |
Abstract: | A yeast .alpha.-factor expression system is provided comprised of a truncated leader sequence, containing the .alpha.-factor signal peptide and one glycosylation site, linked by a processing site to a non-yeast protein-encoding sequence. |
Inventor(s): | Tekamp-Olson; Patricia (San Anselmo, CA) |
Assignee: | Chiron Corporation (Emeryville, CA) |
Application Number: | 09/140,858 |
Patent Claims: | see list of patent claims |
Details for Patent RE37343
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Eli Lilly And Company | HUMULIN R U-100 | insulin human | Injection | 018780 | 10/28/1982 | ⤷ Try a Trial | 2040-03-31 |
Eli Lilly And Company | HUMULIN R U-500 | insulin human | Injection | 018780 | 12/29/2015 | ⤷ Try a Trial | 2040-03-31 |
Eli Lilly And Company | HUMULIN R U-100 | insulin human | Injection | 018780 | 08/06/1998 | ⤷ Try a Trial | 2040-03-31 |
Eli Lilly And Company | HUMULIN R U-500 | insulin human | Injection | 018780 | 03/31/1994 | ⤷ Try a Trial | 2040-03-31 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |